blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2255799

EP2255799 - Agent for combating the side effects of cancer chemotherapy [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.03.2013
Database last updated on 02.11.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU
published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Schunk, Robert
Habichtstrasse 10
81827 München / DE
For all designated states
Krug, Stefanija
Ostallee 49b
54290 Trier / DE
[2012/20]
Former [2011/27]For all designated states
Schunck, Robert
Habichtstrasse 10
81827 München / DE
For all designated states
Krug, Stefanija
Ostallee 49b
54290 Trier / DE
Former [2010/48]For all designated states
Schunck, Robert
Habichtstrasse 10
81827 München / DE
Inventor(s)01 / Krug, Stefanija
Ostallee 49b
54290 Trier / DE
02 / Schunk, Robert
Habichstr. 10
81827 München / DE
 [2010/48]
Representative(s)Bernhardt, Reinhold
Patentanwälte Bernhardt/Wolff
Partnerschaft mbB
Europaallee 17
66113 Saarbrücken / DE
[N/P]
Former [2012/01]Bernhardt, Reinhold
Patentanwälte Bernhardt
Kobenhüttenweg 43
66123 Saarbrücken / DE
Former [2010/48]Bernhardt, Reinold
Patentanwälte Bernhardt Kobenhüttenweg 43
66123 Saarbrücken / DE
Application number, filing date10004550.930.04.2010
[2010/48]
Priority number, dateDE2009102031430.04.2009         Original published format: DE102009020314
[2010/48]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP2255799
Date:01.12.2010
Language:DE
[2010/48]
Type: B1 Patent specification 
No.:EP2255799
Date:16.05.2012
Language:DE
[2012/20]
Search report(s)(Supplementary) European search report - dispatched on:EP22.10.2010
ClassificationIPC:A61K31/23, A61K31/231, A61K31/232, A61K31/355, A61K31/593, A61K31/047, A61K36/185, A61P35/00
[2011/52]
CPC:
A61K31/201 (EP); A61K31/015 (EP); A61K31/202 (EP);
A61K31/355 (EP); A61K31/593 (EP); A61P17/02 (EP);
A61P35/00 (EP) (-)
C-Set:
A61K31/015, A61K2300/00 (EP);
A61K31/201, A61K2300/00 (EP);
A61K31/202, A61K2300/00 (EP);
A61K31/355, A61K2300/00 (EP);
A61K31/593, A61K2300/00 (EP)
(-)
Former IPC [2011/51]A61K31/23, A61K31/231, A61K31/232, A61P35/00, A61K31/355, A61K31/593, A61K31/047
Former IPC [2010/48]A61K31/23, A61K31/231, A61K31/232, A61P35/00, A61K36/185
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2010/48]
TitleGerman:Mittel zur Bekämpfung von Nebenwirkungen der Krebs-Chemotherapie[2010/48]
English:Agent for combating the side effects of cancer chemotherapy[2010/48]
French:Produit destiné à lutter contre les effets secondaires de la chimiothérapie pour le cancer[2010/48]
Examination procedure31.05.2011Amendment by applicant (claims and/or description)
31.05.2011Examination requested  [2011/28]
28.07.2011Despatch of a communication from the examining division (Time limit: M04)
13.10.2011Reply to a communication from the examining division
13.12.2011Communication of intention to grant the patent
28.03.2012Fee for grant paid
28.03.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.07.2011
Opposition(s)19.02.2013No opposition filed within time limit [2013/17]
Fees paidRenewal fee
27.03.2012Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.04.2010
CY16.05.2012
CZ16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
MK16.05.2012
MT16.05.2012
RO16.05.2012
SI16.05.2012
SK16.05.2012
SM16.05.2012
TR16.05.2012
BG16.08.2012
GR17.08.2012
IS16.09.2012
[2015/34]
Former [2015/32]CY16.05.2012
CZ16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
MK16.05.2012
MT16.05.2012
RO16.05.2012
SI16.05.2012
SK16.05.2012
SM16.05.2012
TR16.05.2012
BG16.08.2012
GR17.08.2012
IS16.09.2012
Former [2015/24]CY16.05.2012
CZ16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
MT16.05.2012
RO16.05.2012
SI16.05.2012
SK16.05.2012
SM16.05.2012
BG16.08.2012
GR17.08.2012
IS16.09.2012
Former [2015/13]CY16.05.2012
CZ16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
MT16.05.2012
RO16.05.2012
SI16.05.2012
SK16.05.2012
BG16.08.2012
GR17.08.2012
IS16.09.2012
Former [2014/01]CY16.05.2012
CZ16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
MC16.05.2012
RO16.05.2012
SI16.05.2012
SK16.05.2012
BG16.08.2012
GR17.08.2012
IS16.09.2012
Former [2013/34]CY16.05.2012
CZ16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
RO16.05.2012
SI16.05.2012
SK16.05.2012
BG16.08.2012
GR17.08.2012
IS16.09.2012
Former [2013/10]CY16.05.2012
CZ16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
RO16.05.2012
SI16.05.2012
SK16.05.2012
GR17.08.2012
IS16.09.2012
Former [2013/09]CY16.05.2012
EE16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
SI16.05.2012
GR17.08.2012
IS16.09.2012
Former [2012/51]CY16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
SI16.05.2012
GR17.08.2012
IS16.09.2012
Former [2012/50]CY16.05.2012
HR16.05.2012
LT16.05.2012
LV16.05.2012
GR17.08.2012
IS16.09.2012
Former [2012/49]CY16.05.2012
LT16.05.2012
IS16.09.2012
Former [2012/47]LT16.05.2012
Documents cited:Search[E]EP2201942  (INTENDIS GMBH [DE]) [E] 1,5,12 * claims 1-2,11 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.